BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18717631)

  • 1. Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease.
    Clark J; Simon DK
    Antioxid Redox Signal; 2009 Mar; 11(3):509-28. PubMed ID: 18717631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Mudò G; Mäkelä J; Di Liberto V; Tselykh TV; Olivieri M; Piepponen P; Eriksson O; Mälkiä A; Bonomo A; Kairisalo M; Aguirre JA; Korhonen L; Belluardo N; Lindholm D
    Cell Mol Life Sci; 2012 Apr; 69(7):1153-65. PubMed ID: 21984601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson's disease models through activating the MEF2-PGC1α and BDNF/CREB pathways.
    Chen H; Cao J; Zha L; Wang P; Liu Z; Guo B; Zhang G; Sun Y; Zhang Z; Wang Y
    Aging (Albany NY); 2020 Jul; 12(14):14897-14917. PubMed ID: 32710729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection.
    Kang H; Khang R; Ham S; Jeong GR; Kim H; Jo M; Lee BD; Lee YI; Jo A; Park C; Kim H; Seo J; Paek SH; Lee YS; Choi JY; Lee Y; Shin JH
    Oncotarget; 2017 Jul; 8(30):48603-48618. PubMed ID: 28611284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Agonist and PPAR Gamma Co-Activator 1α (PGC-1α) Activator Ameliorates Cognitive Deficits, Oxidative Stress, and Inflammation in Rodent Model of Parkinson's Disease.
    Das NR; Vaidya B; Khare P; Bishnoi M; Sharma SS
    Curr Neurovasc Res; 2021; 18(5):497-507. PubMed ID: 34923943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models.
    Guo B; Zheng C; Cao J; Luo F; Li H; Hu S; Mingyuan Lee S; Yang X; Zhang G; Zhang Z; Sun Y; Wang Y
    J Adv Res; 2023 Nov; ():. PubMed ID: 37989471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Punctum on two different transcription factors regulated by PGC-1α: nuclear factor erythroid-derived 2-like 2 and nuclear respiratory factor 2.
    Baldelli S; Aquilano K; Ciriolo MR
    Biochim Biophys Acta; 2013 Aug; 1830(8):4137-46. PubMed ID: 23597778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD).
    Zhou ZD; Xie SP; Saw WT; Ho PGH; Wang H; Lei Z; Yi Z; Tan EK
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426448
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroprotective effects of Necdin in the Parkinson's disease.
    Sasaki T; Mochizuki H
    Nihon Rinsho; 2017 Jan; 75(1):36-41. PubMed ID: 30566292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
    Tseng YT; Chang FR; Lo YC
    Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
    Zamanian MY; Parra RMR; Soltani A; Kujawska M; Mustafa YF; Raheem G; Al-Awsi L; Lafta HA; Taheri N; Heidari M; Golmohammadi M; Bazmandegan G
    Mol Biol Rep; 2023 Jun; 50(6):5455-5464. PubMed ID: 37155008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
    Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
    CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
    Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
    Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-nitrosylated PARIS Leads to the Sequestration of PGC-1α into Insoluble Deposits in Parkinson's Disease Model.
    Kim H; Lee JY; Park SJ; Kwag E; Kim J; Shin JH
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model.
    Ahn EH; Kim DW; Shin MJ; Kim YN; Kim HR; Woo SJ; Kim SM; Kim DS; Kim J; Park J; Eum WS; Hwang HS; Choi SY
    Free Radic Biol Med; 2013 Feb; 55():36-45. PubMed ID: 23178948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemfibrozil pretreatment proved protection against acute restraint stress-induced changes in the male rats' hippocampus.
    Khalaj L; Nejad SC; Mohammadi M; Zadeh SS; Pour MH; Ahmadiani A; Khodagholi F; Ashabi G; Alamdary SZ; Samami E
    Brain Res; 2013 Aug; 1527():117-30. PubMed ID: 23850768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways.
    Abdelsalam RM; Safar MM
    J Neurochem; 2015 Jun; 133(5):700-7. PubMed ID: 25752913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease.
    Sita G; Hrelia P; Tarozzi A; Morroni F
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.
    Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ
    Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.